Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression

Susceptibility to bacterial infections after a primary immune stimulation differs drastically depending on the presensitization of the innate immune system. To determine the conditions that either induce protection or enhanced susceptibility to infection with Salmonella enterica serovar Typhimurium,...

Full description

Saved in:
Bibliographic Details
Published in:Infection and Immunity Vol. 73; no. 8; pp. 4905 - 4912
Main Authors: Sterns, Theo, Pollak, Nils, Echtenacher, Bernd, Männel, Daniela N
Format: Journal Article
Language:English
Published: Washington, DC American Society for Microbiology 01-08-2005
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Susceptibility to bacterial infections after a primary immune stimulation differs drastically depending on the presensitization of the innate immune system. To determine the conditions that either induce protection or enhanced susceptibility to infection with Salmonella enterica serovar Typhimurium, we pretreated mice either with tumor necrosis factor (TNF), whole killed bacteria, or sublethal cecal ligation and puncture (CLP) as a mouse model for septic peritonitis. Impaired production of the cytokines TNF, interleukin-6 (IL-6), and IL-10 was induced by these pretreatment schedules, with TNF-signaling not being essential for this effect. Injection of TNF or killed bacteria enhanced survival of mice infected subsequently with serovar Typhimurium. In contrast, sepsis such as that induced by CLP only protected from shock induced by D-galactosamine and lipopolysaccharide or by a high dose of bacteria but sensitized to a secondary bacterial infection. Such sepsis-induced enhanced susceptibility to infection was critically dependent on TNF function.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Editor: F. C. Fang
Corresponding author. Mailing address: Institute of Immunology, University of Regensburg, F.-J.-Strauss-Allee, D-93042 Regensburg, Germany. Phone: 49-941-944-6622. Fax: 49-941-944-6602. E-mail: daniela.maennel@klinik.uni-regensburg.de.
ISSN:0019-9567
1098-5522
DOI:10.1128/IAI.73.8.4905-4912.2005